[go: up one dir, main page]

DK0726766T3 - Hidtil ukendt farmaceutisk praeparat, der indeholder ACE-inhibitoren ramipril og en dihydropyridinforbindelse - Google Patents

Hidtil ukendt farmaceutisk praeparat, der indeholder ACE-inhibitoren ramipril og en dihydropyridinforbindelse

Info

Publication number
DK0726766T3
DK0726766T3 DK95930771T DK95930771T DK0726766T3 DK 0726766 T3 DK0726766 T3 DK 0726766T3 DK 95930771 T DK95930771 T DK 95930771T DK 95930771 T DK95930771 T DK 95930771T DK 0726766 T3 DK0726766 T3 DK 0726766T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical composition
pct
ace inhibitor
composition containing
novel pharmaceutical
Prior art date
Application number
DK95930771T
Other languages
English (en)
Inventor
Brigitte Bauer
Christer Karlsson
Per Johan Lundberg
Berit Nilsson
Anders Sandberg
Alfred Sickmueller
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9402924A external-priority patent/SE9402924D0/xx
Priority claimed from SE9402925A external-priority patent/SE9402925D0/xx
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of DK0726766T3 publication Critical patent/DK0726766T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
DK95930771T 1994-09-02 1995-08-30 Hidtil ukendt farmaceutisk praeparat, der indeholder ACE-inhibitoren ramipril og en dihydropyridinforbindelse DK0726766T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9402924A SE9402924D0 (sv) 1994-09-02 1994-09-02 Novel pharmaceutical composition
SE9402925A SE9402925D0 (sv) 1994-09-02 1994-09-02 Novel oral pharmaceutical composition
PCT/SE1995/000972 WO1996007400A1 (en) 1994-09-02 1995-08-30 Novel pharmaceutical composition containing the ace inhibitor ramipril and a dihydropyridine compound

Publications (1)

Publication Number Publication Date
DK0726766T3 true DK0726766T3 (da) 2002-07-22

Family

ID=26662130

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95930771T DK0726766T3 (da) 1994-09-02 1995-08-30 Hidtil ukendt farmaceutisk praeparat, der indeholder ACE-inhibitoren ramipril og en dihydropyridinforbindelse

Country Status (32)

Country Link
US (1) US6086919A (da)
EP (1) EP0726766B1 (da)
JP (1) JP3776931B2 (da)
KR (1) KR100438133B1 (da)
CN (1) CN1134665A (da)
AT (1) ATE217187T1 (da)
AU (1) AU695865B2 (da)
CA (1) CA2174338C (da)
CZ (1) CZ292224B6 (da)
DE (2) DE726766T1 (da)
DK (1) DK0726766T3 (da)
EE (1) EE03550B1 (da)
EG (1) EG24435A (da)
ES (1) ES2091173T3 (da)
FI (1) FI117616B (da)
GR (1) GR960300055T1 (da)
HU (1) HU226894B1 (da)
IL (1) IL115059A (da)
IS (1) IS1781B (da)
MX (1) MX9601586A (da)
MY (1) MY119489A (da)
NO (1) NO308694B1 (da)
NZ (2) NZ292298A (da)
PL (1) PL186745B1 (da)
PT (1) PT726766E (da)
RU (1) RU2184563C2 (da)
SA (1) SA95160287B1 (da)
SI (1) SI0726766T1 (da)
SK (1) SK283633B6 (da)
TR (1) TR199501077A2 (da)
TW (1) TW483763B (da)
WO (1) WO1996007400A1 (da)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19715594A1 (de) 1997-04-15 1998-10-22 Bayer Ag Analgetika-Kombination
AU1042199A (en) * 1998-11-06 2000-05-29 Boehringer Ingelheim International Gmbh Antihypertensive medicaments containing lacidipine and telmisartan
PE20001302A1 (es) * 1998-11-27 2000-11-30 Hoffmann La Roche Preparaciones de una combinacion farmaceutica que contiene carvedilol e hidroclorotiazida
BR0013704A (pt) 1999-08-30 2002-05-07 Aventis Pharma Gmbh Uso de inibidores do sistema renina-angiotensina na prevenção de casos cardiovasculares
KR100356374B1 (ko) * 2000-09-14 2002-10-19 사회복지법인삼성생명공익재단(삼성서울병원) 안지오텐신 전환효소 억제제의 부작용으로 발생하는마른기침을 저해하기 위한 철분을 포함하는 기침 저해조성물
CA2357982A1 (en) * 2001-09-28 2003-03-28 Bernard Charles Sherman Solid compositions comprising ramipril
EP1467717A1 (en) * 2002-01-15 2004-10-20 Ranbaxy Laboratories Limited Stable pharmaceutical compositions comprising ace inhibitor(s)
USD481456S1 (en) 2002-01-30 2003-10-28 Smithkline Beecham P.L.C. Capsule
US6844361B2 (en) * 2002-02-04 2005-01-18 Aventis Pharma Deutschland Gmbh Pharmaceutical composition comprising a sodium hydrogen exchange inhibitor and an angiotensin converting enzyme inhibitor
US20030175342A1 (en) * 2002-03-14 2003-09-18 Karl Kolter Coated pharmaceutical single-unit delayed-release forms, based on polyvinyl acetate
US20030211149A1 (en) * 2002-05-07 2003-11-13 Sherman Bernard Charles Extended release tablets comprising felodipine
US6663892B1 (en) 2002-08-19 2003-12-16 L. Perrigo Company Multiple portion tablet
US20050101640A1 (en) * 2002-10-16 2005-05-12 Recordati Ireland Limited Lisinopril/lercanidipine combination therapy
US20040147566A1 (en) * 2002-10-16 2004-07-29 Amedeo Leonardi Lisinopril/lercanidipine combination therapy
BR0317028A (pt) * 2002-12-10 2005-10-25 Novartis Ag Combinação de um inibidor de dpp-iv e um composto de ppar-alfa
GB0301471D0 (en) * 2003-01-22 2003-02-19 Biochemie Gmbh Organic compounds
PT1635792E (pt) * 2003-06-26 2009-05-15 Teva Pharma Composições farmacêuticas estáveis de derivados do ácido 2-aza-biciclo[3.3.0]octano-3-carboxílico
JP2007517766A (ja) * 2003-09-24 2007-07-05 コンビナトアールエックス インコーポレーティッド 薬物の組み合わせを投与するための治療法
DE102004008804A1 (de) * 2004-02-20 2005-09-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Mehrschichttablette
GB2411355B (en) 2004-02-27 2006-02-22 Niche Generics Ltd Pharmaceutical composition
TW200534879A (en) * 2004-03-25 2005-11-01 Bristol Myers Squibb Co Coated tablet formulation and method
US20050256314A1 (en) * 2004-05-04 2005-11-17 Soojin Kim Process employing controlled crystallization in forming crystals of a pharmaceutical
US7829720B2 (en) * 2004-05-04 2010-11-09 Bristol-Myers Squibb Company Process for preparing atazanavir bisulfate and novel forms
US20050288343A1 (en) * 2004-05-19 2005-12-29 Andrew Rusowicz Process of preparing substituted carbamates and intermediates thereof
US7713547B2 (en) 2004-05-21 2010-05-11 Accu-Break Pharmaceuticals, Inc. Method of administering a partial dose of a segmented pharmaceutical tablet
US7318935B2 (en) * 2004-05-21 2008-01-15 Accu-Break Technologies, Inc. Pharmaceutical tablets with active and inactive segments
US7622137B2 (en) * 2004-05-21 2009-11-24 Accu-Break Technologies, Inc. Dosage forms contained within a capsule or sachet
US7780985B2 (en) * 2005-07-12 2010-08-24 Accu-Break Technologies, Inc. Tablets having a printed separation mark to guide breaking
US7329418B2 (en) * 2004-05-21 2008-02-12 Accu Break Technologies, Inc. Pharmaceutical tablets having height greater than width
US7838031B2 (en) 2004-05-21 2010-11-23 Lawrence Solomon Method of administering a partial dose using a segmented pharmaceutical tablet
EP1746979B1 (en) * 2004-05-21 2013-09-11 Accu-Break Technologies, Inc. Scored pharmaceutical tablets comprising a plurality of segments
TWI354569B (en) 2004-05-28 2011-12-21 Bristol Myers Squibb Co Coated tablet formulation and method
KR100593795B1 (ko) 2004-10-12 2006-06-30 대원제약주식회사 안정성이 개선된 라미프릴을 포함하는 경구투여용 제제
ZA200704767B (en) * 2004-11-05 2008-08-27 King Pharmaceuticals Res & Dev Stabilized individually coated ramipril particles, compositions and methods
KR100714616B1 (ko) * 2005-06-23 2007-05-07 삼성전기주식회사 지수 함수 발생기 및 이를 이용한 가변 이득 증폭기
CN101252837A (zh) * 2005-07-28 2008-08-27 瑞莱恩特医药品有限公司 用二氢吡啶类钙通道阻断剂和Omega-3脂肪酸及其组合产品的治疗
US20070116762A1 (en) * 2005-11-07 2007-05-24 Wilson Edward S Compositions of stabilized ramipril in combination with another active agent
WO2007058660A1 (en) * 2005-11-18 2007-05-24 Accu-Break Technologies, Inc. Segmented pharmaceutical dosage forms
US20070237815A1 (en) * 2006-04-06 2007-10-11 Lawrence Solomon Dosage forms and methods comprising amlodipine and chlorthalidone
KR20080112387A (ko) * 2006-04-19 2008-12-24 테바 파마슈티컬 인더스트리즈 리미티드 2-아자-비사이클로[3.3.0]-옥탄-3-카르복실산 유도체의 안정한 약학 조성물
US20080075771A1 (en) * 2006-07-21 2008-03-27 Vaughn Jason M Hydrophilic opioid abuse deterrent delivery system using opioid antagonists
JP2010500374A (ja) * 2006-08-08 2010-01-07 エーシーシーユー−ブレイク テクノロジーズ，インク． 複数の活性セグメントを含む薬剤の錠剤
EP2083801A1 (en) * 2006-11-30 2009-08-05 Accu-Break Technologies, Inc. Divisible osmotic dosage forms and methods of use
GB0624090D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amine salts
GB0624084D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amino acid salts
GB0624087D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril combination salt
AU2008268625B2 (en) * 2007-06-22 2013-11-28 Bristol-Myers Squibb Holdings Ireland Unlimited Company Tableted compositions containing atazanavir
AU2008268627A1 (en) * 2007-06-22 2008-12-31 Bristol-Myers Squibb Company Tableted compositions containing atazanavir
PT2178513E (pt) * 2007-06-22 2011-05-31 Bristol Myers Squibb Co Composi??es em comprimido que cont?m atazanavir
WO2009002826A2 (en) * 2007-06-22 2008-12-31 Bristol-Myers Squibb Company Tableted compositions containing atazanavir
RU2493832C2 (ru) * 2008-01-25 2013-09-27 Дюо-Же Комбинации пероральных лекарственных средств, соединенных посредством оболочки
MY156305A (en) * 2008-07-28 2016-01-29 Takeda Pharmaceutical Pharmaceutical composition
DE102008059206A1 (de) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
SI23149A (sl) 2009-09-21 2011-03-31 Silverstone Pharma Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni
CN101843892B (zh) * 2010-05-18 2013-03-06 广州白云山制药股份有限公司广州白云山制药总厂 包括依那普利速释部分和非洛地平缓释部分的药物组合物制剂
EP3169331A4 (en) * 2014-07-17 2018-01-17 Jerome J. Schentag Activation of the endogenous ileal brake hormone pathway for organ regeneration and related compositions, methods of treatment, diagnostics, and regulatory systems

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670827C3 (de) * 1967-03-20 1974-10-24 Bayer Ag, 5090 Leverkusen 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
SE429652B (sv) * 1978-06-30 1983-09-19 Haessle Ab 2.6-dimetyl-4-(2.3-diklorfenyl)-1.4-dihydropyridin-3.5-dikarboxylsyra-3-metylester-5-etylester
DE3413710A1 (de) * 1984-04-12 1985-10-24 Hoechst Ag, 6230 Frankfurt Verfahren zur behandlung der herzinsuffizienz
NZ212895A (en) * 1984-08-22 1988-07-28 Glaxo Spa 1,4-dihydropyridine derivatives and pharmaceutical compositions
DE3437917A1 (de) * 1984-10-17 1986-04-17 Bayer Ag, 5090 Leverkusen Kombination von dihydropyridinen mit ace-hemmern sowie ihre verwendung in arzneimitteln
DE3633496A1 (de) * 1986-10-02 1988-04-14 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit calciumantagonisten sowie deren verwendung in arzneimitteln
DE3704661A1 (de) * 1987-02-14 1988-08-25 Hoechst Ag Annelierte azepinon- und azocinon-derivate, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung, sowie zwischenprodukte bei ihrer herstellung
US4743450A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
CA1323833C (en) * 1987-04-28 1993-11-02 Yatindra M. Joshi Pharmaceutical compositions in the form of beadlets and method
DE3739690A1 (de) * 1987-11-24 1989-06-08 Hoechst Ag Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen
TW197945B (da) * 1990-11-27 1993-01-11 Hoechst Ag
DE4109134A1 (de) * 1991-03-20 1992-09-24 Knoll Ag Erzeugnisse, enthaltend verapamil und trandolapril
CA2070085A1 (en) * 1991-05-31 1992-12-01 Gerald P. Polli Ace inhibitor and calcium channel blocker for use in treating hypertension
US5160744A (en) * 1991-06-27 1992-11-03 Alza Corporation Verapmil therapy
US5178867A (en) * 1991-08-19 1993-01-12 Alza Corporation Dosage form for delivering drug in short-time period
ES2193233T3 (es) * 1995-03-16 2003-11-01 Pfizer Uso de amiodipina, una sal de la misma o felodipina en combinacion con un inhibidor ace en la fabricacion de un medicamento para el tratamiento de insuficiencia cardiaca conjuntiva no isquemica.

Also Published As

Publication number Publication date
SA95160287B1 (ar) 2006-05-28
MY119489A (en) 2005-06-30
EP0726766B1 (en) 2002-05-08
IS4337A (is) 1996-04-18
NO961726L (no) 1996-04-29
PT726766E (pt) 2002-10-31
CZ292224B6 (cs) 2003-08-13
DE726766T1 (de) 1997-01-30
NO961726D0 (no) 1996-04-29
MX9601586A (es) 1998-01-31
NZ329556A (en) 2000-07-28
SA95160287A (ar) 2005-12-03
CA2174338A1 (en) 1996-03-14
KR100438133B1 (ko) 2004-09-04
EP0726766A1 (en) 1996-08-21
EE03550B1 (et) 2001-12-17
ATE217187T1 (de) 2002-05-15
WO1996007400A1 (en) 1996-03-14
DE69526640D1 (de) 2002-06-13
TW483763B (en) 2002-04-21
PL186745B1 (pl) 2004-02-27
HU226894B1 (en) 2010-01-28
ES2091173T1 (es) 1996-11-01
TR199501077A2 (tr) 1996-06-21
PL314084A1 (en) 1996-08-19
EG24435A (en) 2009-06-25
EE9600072A (et) 1996-12-16
JP3776931B2 (ja) 2006-05-24
JPH09504806A (ja) 1997-05-13
AU3402995A (en) 1996-03-27
SK283633B6 (sk) 2003-11-04
FI961863L (fi) 1996-05-02
US6086919A (en) 2000-07-11
HU9601146D0 (en) 1996-07-29
RU2184563C2 (ru) 2002-07-10
IL115059A0 (en) 1996-01-19
FI117616B (fi) 2006-12-29
NO308694B1 (no) 2000-10-16
CA2174338C (en) 2009-11-03
ES2091173T3 (es) 2002-12-01
HK1001811A1 (en) 1998-07-10
CN1134665A (zh) 1996-10-30
AU695865B2 (en) 1998-08-27
NZ292298A (en) 1998-02-26
IS1781B (is) 2001-10-01
FI961863A0 (fi) 1996-05-02
IL115059A (en) 2003-10-31
SK55896A3 (en) 1997-03-05
CZ117396A3 (en) 1996-09-11
SI0726766T1 (en) 2002-10-31
GR960300055T1 (en) 1996-10-31
HUT76049A (en) 1997-06-30
DE69526640T2 (de) 2002-11-07

Similar Documents

Publication Publication Date Title
DK0726766T3 (da) Hidtil ukendt farmaceutisk praeparat, der indeholder ACE-inhibitoren ramipril og en dihydropyridinforbindelse
FI960102A0 (fi) Uusi farmaseuttinen seos
CY1107245T1 (el) Φαρμακευτικες συνθεσεις αμλοδιπινης και ατορβαστατινης
NO20045434L (no) En kombinasjon av en NMDA-antagonist og acetylkolinesteraseinhibitorer for behandlingen av Alzheimers sykdom
DK0760661T3 (da) Farmaceutiske sammensætninger omfattende en opiat-antagonist og calciumsalte, deres anvendelse til behandling af endorfin-m
DK0758241T3 (da) Anvendelse af visse methanbisphosphonsyrederivater til at hindre løsning og vandring af proteser
FI972434A0 (fi) Lamotrigiiniä sisältävä farmaseuttinen koostumus
DK0649654T3 (da) Anvendelse af en kombination af ACE-inhibitor og calciumantagonist til behandling af proteinuria